BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $88,000 | +23.9% | 584 | +21.7% | 0.00% | – |
| Q2 2022 | $71,000 | -19.3% | 480 | -34.7% | 0.00% | – |
| Q1 2022 | $88,000 | -33.8% | 735 | -24.0% | 0.00% | – |
| Q4 2021 | $133,000 | +18.8% | 967 | +19.7% | 0.00% | – |
| Q3 2021 | $112,000 | +57.7% | 808 | +9.8% | 0.00% | – |
| Q2 2021 | $71,000 | +24.6% | 736 | -12.9% | 0.00% | – |
| Q1 2021 | $57,000 | -60.4% | 845 | -49.6% | 0.00% | – |
| Q4 2020 | $144,000 | +26.3% | 1,676 | -3.7% | 0.00% | – |
| Q3 2020 | $114,000 | -8.1% | 1,741 | +1.5% | 0.00% | – |
| Q2 2020 | $124,000 | +12300.0% | 1,715 | +6251.9% | 0.00% | – |
| Q1 2020 | $1,000 | -75.0% | 27 | -68.6% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 86 | -13.1% | 0.00% | – |
| Q2 2019 | $5,000 | – | 99 | +280.8% | 0.00% | – |
| Q1 2018 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 26 | +8.3% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 24 | -40.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |